Area of research
Molecular Biology · Infectious Diseases
Research interest
Research interests include Tuberculosis, Mycobacterium tuberculosis, Dysbiosis, Microbiome, Antibiotics, and Immunology.
Bacterial-induced or passively administered interferon gamma conditions the lung for early control of SARS-CoV-2
BACH1 promotes tissue necrosis and Mycobacterium tuberculosis susceptibility
PD-1 blockade exacerbates <i>Mycobacterium tuberculosis</i> infection in rhesus macaques
The Microbiome and Tuberculosis: Early Evidence for Cross Talk
Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed
Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy